Active Pharmaceutical Ingredient (API) Market, 2024 by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone, Biosimilar) Drug (OTC, Rx) - ResearchAndMarkets.com
The "Active Pharmaceutical Ingredient/ API Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product (mAb, Hormone, Biosimilar) Drug (OTC, Rx), Therapy, and Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global APIs market is projected to reach USD 245.2 billion by 2024 from USD 182.2 billion in 2019, at a CAGR of 6.1% during the forecast period.
The increasing incidence of chronic diseases, growing importance of generics, and the increasing uptake of biopharmaceuticals are some of the major factors driving the growth of the global APIs market. On the other hand, the unfavorable drug price control policies across various countries and the increasing penetration of counterfeit drugs are expected to restrain the growth of this market in the coming years.
The major factors driving the overall growth of the APIs market in this region include the growing incidence of preventable chronic diseases, increasing government focus on generic drugs, rising demand for biologics and specialty drugs, and technological advancements in the manufacturing processes of APIs. This market segment is expected to grow at a modest rate due to a combination of economic and healthcare severity measures and the introduction of low-cost, generic versions of branded drugs.
In this report, the APIs market is segmented on the basis of type, type of manufacturer, type of synthesis, type of drug, potency, and therapeutic application.
Geographically, the active pharmaceutical ingredients market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2019, North America is expected to dominate the market, followed by Europe.
Some of the prominent players in the market include
- Abbvie Inc.
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Eli Lilly and Company
- F. Hoffmann-La Roche
- Glaxosmithkline PLC
- Merck & Co., Inc.
- Novartis AG
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Active Pharmaceutical Ingredients Market, By Type
7 Active Pharmaceutical Ingredients Market, By Type of Manufacturer
8 Active Pharmaceutical Ingredients Market, By Type of Synthesis
9 Active Pharmaceutical Ingredients Market, By Type of Drug
10 Active Pharmaceutical Ingredients Market, By Therapeutic Application
11 Active Pharmaceutical Ingredients Market, By Region
12 Competitive Landscape
13 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/vtvx7c/active?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20190115005353/en/